Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

RETIN-A RESEARCHER FUNDING FROM ORTHO QUESTIONED BY REP. WEISS (D-NY)

Executive Summary

RETIN-A RESEARCHER FUNDING FROM ORTHO QUESTIONED BY REP. WEISS (D-NY) in a report on scientific conduct and conflicts of interest issued by the House Human Resources and Intergovernmental Relations Subcommittee. Weiss alleges a potential conflict-of-interest by one of the authors of the report on Retin-A use against photoaging in the Jan. 1988 issue of the Journal of the American Medical Association. The author, John Voorhees received $253,120 in research grants from Ortho in the year before publication of the results and $689,750 the following year. Voorhees is also alleged to have received 13 honoraria payments in 1988 including a press conference to announce the results of the Retin-A study. Weiss tallied the financial data from information provided to the subcommittee by Johnson & Johnson. The Weiss review attempts to keep alive the subject of research objectivity, research funding and the subsequent publicity of research findings by doctors receiving grants, honoraria and consulting fees.
UsernamePublicRestriction

Register

PS018039

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel